Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1993;19(7):390–394. doi: 10.1007/BF01724878

Angiotensin-converting enzyme activity in serum and bronchoalveolar lavage fluid after damage to the alveolo-capillary barrier in the human lung

R F De Jongh 1, W A De Backer 2, R Mohan 2, P G Jorens 2, F J van Overveld 2
PMCID: PMC7095338  PMID: 8270718

Abstract

Objective

Angiotensin-converting enzyme (ACE) is considered as a possible marker for endothelial cell damage in serum or bronchoalveolar lavage fluid. This hypothesis was tested during cardiac surgery and during the adult respiratory distress syndrome.

Design

We used patients with an expected different degree of endothelial cell damage. ACE levels in serum and bronchoalveolar lavage fluid were compared with indirect markers of alveolo-capillary barrier integrity.

Setting

Interdisciplinary team in a university hospital.

Methods

13 Cardiac surgery patients received no glucocorticoids and 13 others received 2g methylprednisolone before extracorporeal circulation. Thirteen patients were used as controls and 15 patients had nonseptic adult respiratory distress syndrome. All underwent bronchoalveolar lavage for ACE determination.

Results

At different times during surgery serum angiotensin-converting enzyme levels were not significantly different between the two groups. In post-operative bronchoalveolar lavage fluid, angiotensin-converting enzyme levels were significantly higher in patients who received corticoids (27.8±1.7U/1, mean±SEM), compared to patients without corticoids (19.8±1.4U/1), control patients (18.2±1.3U/1) or patients with full blown non-septic adult respiratory distress syndrome (18.8±1.1U/1). There were no correlations between lavage angiotensin-converting enzyme and other parameters for alveolo-capillary membrane integrity in the lavage fluid such as the number of neutrophil cells, albumin or protein concentration, and between lavage angiotensin-converting enzyme and PaO2/FIO2 ratio during lavage.

Conclusion

Angiotensin-converting enzyme activity in serum or bronchoalveolar lavage fluid does not reflect damage of endothelial cells or damage of alveolocapillary integrity in acute pulmonary disease.

Key words: Angiotensin-converting enzyme, Glucocorticoids, Methylprednisolone, Endothelial cell, Cardiac surgery, Extracorporeal circulation, Adult respiratory distress syndrome

References

  • 1.Ryan VS, Ryan IW, Whitaker C, Chin A. Localization of angiotensin-converting enzyme (kinase II). II. Immunocytochemistry and immunofluorescence. Tissue Cell. 1976;8:125–145. doi: 10.1016/0040-8166(76)90025-2. [DOI] [PubMed] [Google Scholar]
  • 2.Friedland J, Setton C, Silverstein E. Angiotensin enzyme induction by steroids in rabbit alveolar macrophages in culture. Science. 1979;205:202–203. doi: 10.1126/science.194311. [DOI] [PubMed] [Google Scholar]
  • 3.Rubin D, Mason R, Dobbs L. Angiotensin-converting enzyme substrates hydrolyzed by fibroblasts and vascular endothelial cells. Exp Lung Res. 1982;3:137–145. doi: 10.3109/01902148209063288. [DOI] [PubMed] [Google Scholar]
  • 4.Hollinger M. Serum angiotensin-converting enzyme. Status report on its diagnostic significance in pulmonary disease. Chest. 1983;83:589–590. [Google Scholar]
  • 5.Ratliff NB, Young WG, Hacket DB, Mikat E, Wilson JW. Pulmonary injury secondary to extracorporeal circulation: an ultrastructural study. J Thorac Cardiovasc Surg. 1973;65:425–432. [PubMed] [Google Scholar]
  • 6.Hollinger M, Giri S, Patwell S, Zuckerman J, Gorin A, Parsons G. Effect of acute lung injury on angiotensin-converting enzyme in serum, lung lavage, and effusate. Am Rev Respir Dis. 1980;121:373–376. doi: 10.1164/arrd.1980.121.2.373. [DOI] [PubMed] [Google Scholar]
  • 7.Shasby D, Shasby S, Bowman C, et al. Angiotensin-converting enzyme concentrations in the lung lavage of normal rabbits and rabbits treated with nitrogen mustered exposed to hyperoxia. Am Rev Respir Dis. 1981;124:202–203. doi: 10.1164/arrd.1981.124.2.202. [DOI] [PubMed] [Google Scholar]
  • 8.Newman R, Kimberly P, Stewart J, Kelley J. Assessment of bleomycin lung toxicity using angiotensin-converting enzyme in pulmonary lavage. Cancer Res. 1980;40:3621–3626. [PubMed] [Google Scholar]
  • 9.Kelly J. Lavage angiotensin-converting enzyme as a marker of lung injury. Am Rev Respir Dis. 1988;137:531–534. doi: 10.1164/ajrccm/137.3.531. [DOI] [PubMed] [Google Scholar]
  • 10.Bull H, Thornberry N, Cordes E. Purification of angiotensin-converting enzyme form rabbit lung and human plasma by affinity chromatography. J Biol Chem. 1985;260:2963–2972. [PubMed] [Google Scholar]
  • 11.De Backer W, Verpooten G, Borgonjon D, Vermeire P, De Broe M. Hypoxemia during hemodialysis: effect of different membranes and dialysate compostions. Kidney Int. 1983;23:738–743. doi: 10.1038/ki.1983.87. [DOI] [PubMed] [Google Scholar]
  • 12.Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845–847. [PubMed] [Google Scholar]
  • 13.Tennenberg SD, Bailey WW, Cotta LA, Brodt JK, Solomkin JS. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass. Surgery. 1986;100:134–141. [PubMed] [Google Scholar]
  • 14.Hammerschmidt DE, Flynn PJ, Coppo PA, Skubitz KM, Jacob HS. Synergy among agents inhibiting granulocyte aggregation. Inflammation. 1982;6:169–176. doi: 10.1007/BF00916241. [DOI] [PubMed] [Google Scholar]
  • 15.Hammerschmidt DE, Stroncek DF, Bowers TK, Lammi-Keefe CJ, Kurth DM, Ozalins A, Nicoloff DM, Lilehei RC, Craddock PR, Jacob HS. Complement activation and neutropenia occuring during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1981;81:370–377. [PubMed] [Google Scholar]
  • 16.Neels HM, Scharpé SL, van Sande ME, Fonteyne GA. Singlereagent microcentrifugal assay for angiotensin converting enzyme in serum. Clin Chem. 1984;30:163. [PubMed] [Google Scholar]
  • 17.Hendriks D, Scharpé SL, van Sande ME, Vingerhoed JP. Single-reagent automated determination of angiotensin converting enzyme in serum. Clin Chem. 1985;31:1761. [PubMed] [Google Scholar]
  • 18.Hammerschmidt DE, White JG, Craddock PR, Jacob HS. Corticosteroids inhibit complement-induced granulocyte aggregation: a possible mechanism for their efficacy in shock states. J Clin Invest. 1979;63:798–803. doi: 10.1172/JCI109365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Boscoe MJ, Yewdall VM, Thompson MA, Cameron JS. Complement activation during cardiopulmonary bypass; quantitative study of effects of methylprednisolone and pulsatile flow. Br Med J. 1983;287:1747–1750. doi: 10.1136/bmj.287.6407.1747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Fosse E, Mollnes TE, Osterud A, Aasen AO. Effects of methylprednisolone on complement activation and leucocyte counts during cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg. 1987;21:255–261. doi: 10.3109/14017438709106035. [DOI] [PubMed] [Google Scholar]
  • 21.Ryder KW, Jay SJ, Jackson SA, Hoke SR. Characterization of a spectrophotometric assay for angiotensin converting enzyme. Clin Chem. 1981;27:530–534. [PubMed] [Google Scholar]
  • 22.Idell S, Kueppers F, Lippmann M, Rosen H, Niederman M, Fein A. Angiotensin converting enzyme in bronchoalveolar lavage in ARDS. Chest. 1987;91:52–56. doi: 10.1378/chest.91.1.52. [DOI] [PubMed] [Google Scholar]
  • 23.Mendelsohn FA, Lloyd CJ, Kachel C, Funder JW. Induction by glucocorticoids of angiotensin converting enzyme production from bovine endothelial cells in culture and rat lung in vivo. J Clin Invest. 1982;70:684–692. doi: 10.1172/JCI110663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Friedland J, Setton C, Silverstein E. Angiotensin converting enzyme: induction by steroids in rabbit alveolar macrophages in culture. Science. 1977;197:64–65. doi: 10.1126/science.194311. [DOI] [PubMed] [Google Scholar]
  • 25.Bergstrand H, Bjornson A, Blaschke E, Brattsand R, Eklund A, Larsson K, Linden M. Effects of an inhaled corticosteroid, budesonide, on alveolar macrophage function in smokers. Thorax. 1990;45:362–368. doi: 10.1136/thx.45.5.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Verma PS, Adams RG, Miller RL. Inhibition of canine lung angiotensin converting enzyme by substance P. Eur J Pharmacol. 1983;86:275–277. doi: 10.1016/0014-2999(82)90326-0. [DOI] [PubMed] [Google Scholar]
  • 27.Piedimonte G, McDonald DM, Nadel JA. Glucocorticoids inhibit neurogenic plasma extravasation and prevent virus-potentiated extravasation in the rat trachea. J Clin Invest. 1990;86:1409–1415. doi: 10.1172/JCI114855. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Intensive Care Medicine are provided here courtesy of Nature Publishing Group

RESOURCES